ANIXA BIOSCIENCES, INC. Other than Temporary Impairment Losses, Investments
ANIXA BIOSCIENCES, INC. (ANIX) reported Other than Temporary Impairment Losses, Investments of $10.82 million for the 3-month period ending 2013-01-31, per its 10-Q/A filed 2013-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2013-03-25
- ANIXA BIOSCIENCES, INC. other than temporary impairment losses, investments for the quarter ending 2013-01-31 was $10.82M.
- ANIXA BIOSCIENCES, INC. other than temporary impairment losses, investments for the quarter ending 2011-10-31 was $1.72M.
- ANIXA BIOSCIENCES, INC. other than temporary impairment losses, investments for fiscal 2012 was $127.50K.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|
| 2013-01-31 | $10.82M 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | $127.50K 10-K · filed 2013-01-29 | |
| 2011-10-31 | $1.72M 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |